Gryphon Financial Partners’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$500K Buy
1,123
+5
+0.4% +$2.23K 0.07% 182
2025
Q1
$542K Buy
1,118
+64
+6% +$31K 0.08% 156
2024
Q4
$424K Sell
1,054
-815
-44% -$328K 0.06% 169
2024
Q3
$869K Buy
1,869
+316
+20% +$147K 0.12% 104
2024
Q2
$728K Sell
1,553
-9
-0.6% -$4.22K 0.11% 111
2024
Q1
$653K Sell
1,562
-416
-21% -$174K 0.11% 123
2023
Q4
$486K Buy
1,978
+414
+26% +$102K 0.09% 151
2023
Q3
$544K Sell
1,564
-1
-0.1% -$348 0.13% 90
2023
Q2
$551K Buy
1,565
+26
+2% +$9.15K 0.12% 94
2023
Q1
$485K Buy
1,539
+6
+0.4% +$1.89K 0.11% 102
2022
Q4
$443K Sell
1,533
-2
-0.1% -$578 0.11% 109
2022
Q3
$445K Buy
1,535
+17
+1% +$4.93K 0.11% 103
2022
Q2
$428K Sell
1,518
-3
-0.2% -$846 0.1% 112
2022
Q1
$396K Sell
1,521
-74
-5% -$19.3K 0.08% 132
2021
Q4
$350K Sell
1,595
-167
-9% -$36.6K 0.07% 148
2021
Q3
$320K Sell
1,762
-178
-9% -$32.3K 0.07% 142
2021
Q2
$503K Buy
1,940
+42
+2% +$10.9K 0.11% 90
2021
Q1
$407K Buy
1,898
+10
+0.5% +$2.14K 0.09% 115
2020
Q4
$446K Sell
1,888
-20
-1% -$4.73K 0.11% 97
2020
Q3
$522K Buy
1,908
+20
+1% +$5.47K 0.15% 70
2020
Q2
$548K Sell
1,888
-166
-8% -$48.2K 0.17% 61
2020
Q1
$488K Sell
2,054
-127
-6% -$30.2K 0.18% 62
2019
Q4
$478K Buy
2,181
+21
+1% +$4.6K 0.12% 90
2019
Q3
$366K Sell
2,160
-5
-0.2% -$847 0.11% 108
2019
Q2
$397K Sell
2,165
-7
-0.3% -$1.28K 0.11% 91
2019
Q1
$399K Sell
2,172
-8
-0.4% -$1.47K 0.12% 88
2018
Q4
$361K Sell
2,180
-32
-1% -$5.3K 0.09% 141
2018
Q3
$427K Buy
2,212
+1,974
+829% +$381K 0.13% 91
2018
Q2
$40K Sell
238
-10
-4% -$1.68K 0.02% 266
2018
Q1
$41K Buy
248
+2
+0.8% +$331 0.02% 258
2017
Q4
$37K Buy
+246
New +$37K 0.02% 303